Affiliation:
1. Department of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, LA 70112, USA
2. Department of Surgery, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA
Abstract
The obesity epidemic is associated with increased colorectal cancer (CRC) risk and progression, the mechanisms of which remain unclear. In obese individuals, hypertrophic epiploic adipose tissue (EPAT), attached to the colon, has unique characteristics compared to other fats. We hypothesized that this understudied fat could serve as a tumor-promoting tissue and developed a novel microphysiological system (MPS) for human EPAT-dependent colorectal cancer (CRC-MPS). In CRC-MPS, obese EPAT, unlike lean EPAT, considerably attracted colon cancer HT29-GFP cells and enhanced their growth. Conditioned media (CM) from the obese CRC-MPS significantly increased the growth and migration of HT29 and HCT116 cells (p < 0.001). In HT29 cells, CM stimulated differential gene expression (hOEC867) linked to cancer, tumor morphology, and metabolism similar to those in the colon of high-fat-diet obese mice. The hOEC867 signature represented pathways found in human colon cancer. In unsupervised clustering, hOEC867 separated transcriptomes of colon cancer samples from normal with high significance (PCA, p = 9.6 × 10−11). These genes, validated in CM-treated HT29 cells (p < 0.05), regulate the cell cycle, cancer stem cells, methylation, and metastasis, and are similarly altered in human colon cancer (TCGA). These findings highlight a tumor-promoting role of EPAT in CRC facilitated with obesity and establishes a platform to explore critical mechanisms and develop effective treatments.
Funder
NIH
Crohn’s & Colitis Foundation
Reference38 articles.
1. Obesity: Global epidemiology and pathogenesis;Bluher;Nat. Rev. Endocrinol.,2019
2. Epidemiology of colorectal cancer: Incidence, mortality, survival, and risk factors;Rawla;Gastroenterol. Rev.,2019
3. Colon Cancer and Obesity: A Narrative Review;Duraiyarasan;Cureus,2022
4. Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management;Shah;Gastroenterology,2022
5. Nenkov, M., Ma, Y., Gassler, N., and Chen, Y. (2021). Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy. Int. J. Mol. Sci., 22.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献